{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T12:40:24Z","timestamp":1787920824677,"version":"build-2784847793"},"reference-count":19,"publisher":"The Endocrine Society","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[1998,5,1]]},"abstract":"<jats:p>The molecular basis of parathyroid adenomatosis includes defects in the cyclin D1\/PRAD1 and MEN1 genes but is, in large part, unknown. To identify new locations of parathyroid oncogenes or tumor suppressor genes, and to further establish the importance of DNA losses described by molecular allelotyping, we performed comparative genomic hybridization (CGH) on a panel of 53 typical sporadic (nonfamilial) parathyroid adenomas. CGH is a new molecular cytogenetic technique in which the entire tumor genome is screened for chromosomal gains and\/or losses. Two abnormalities, not previously described, were found recurrently: gain of chromosome 16p (6 of 53 tumors, or 11%) and gain of chromosome 19p (5 of 53, or 9%). Losses were found frequently on 11p (14 of 53, or 26%), as well as 11q (18 of 53, or 34%). Recurrent losses were also seen on chromosomes 1p, 1q, 6q, 9p, 9q, 13q, and 15q, with frequencies ranging from 8\u201319%. Twenty-four of the 53 adenomas were also extensively analyzed with polymorphic microsatellite markers for allelic losses, either in this study (11 cases) or previously (13 cases). Molecular allelotyping results were highly concordant with CGH results in these tumors (concordance level of 97.5% for all informative markers\/chromosome arms examined).<\/jats:p>\n               <jats:p>In conclusion, CGH has identified the first two known chromosomal gain defects in parathyroid adenomas, suggesting the existence of direct-acting parathyroid oncogenes on chromosomes 16 and 19. CGH has confirmed the locations of putative parathyroid tumor suppressor genes, also defined by molecular allelotyping, on chromosomes 1p, 6q, 9p, 11q, 13q, and 15q. Finally, CGH has provided new evidence favoring the possibility that distinct parathyroid tumor suppressors exist on 1p and 1q, and has raised the possibility of a parathyroid tumor suppressor gene on 11p, distinct from the MEN1 gene on 11q. CGH can identify recurrent genetic abnormalities in hyperparathyroidism, especially chromosomal gains, that other methods do not detect.<\/jats:p>","DOI":"10.1210\/jcem.83.5.4806","type":"journal-article","created":{"date-parts":[[2014,1,8]],"date-time":"2014-01-08T17:02:55Z","timestamp":1389200575000},"page":"1766-1770","source":"Crossref","is-referenced-by-count":6,"title":["Novel Chromosomal Abnormalities Identified by Comparative Genomic Hybridization in Parathyroid Adenomas1"],"prefix":"10.1210","volume":"83","author":[{"given":"Nallasivam","family":"Palanisamy","sequence":"first","affiliation":[{"name":"Cell Biology Program (N.P., P.H.R., R.S.K.C.), Memorial Sloan-Kettering Cancer Center, New York, New York 10021;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Imanishi","sequence":"additional","affiliation":[{"name":"Laboratory of Endocrine Oncology (Y.I., H.T., A.A.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114;"},{"name":"Center for Molecular Medicine (Y.I., A.A.), University of Connecticut School of Medicine, Farmington, Connecticut 06030-1316"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pulivarthi H.","family":"Rao","sequence":"additional","affiliation":[{"name":"Cell Biology Program (N.P., P.H.R., R.S.K.C.), Memorial Sloan-Kettering Cancer Center, New York, New York 10021;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Tahara","sequence":"additional","affiliation":[{"name":"Laboratory of Endocrine Oncology (Y.I., H.T., A.A.), Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts 02114;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. S. K.","family":"Chaganti","sequence":"additional","affiliation":[{"name":"Cell Biology Program (N.P., P.H.R., R.S.K.C.), Memorial Sloan-Kettering Cancer Center, New York, New York 10021;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Arnold","sequence":"additional","affiliation":[{"name":"Center for Molecular Medicine (Y.I., A.A.), University of Connecticut School of Medicine, Farmington, Connecticut 06030-1316"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071618434670100_R1","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1038\/350512a0","article-title":"A novel cyclin encoded by a bcl1-linked candidate oncogene.","volume":"350","author":"Motokura","year":"1991","journal-title":"Nature"},{"key":"2020071618434670100_R2","first-page":"543","article-title":"The cyclin D1\/PRAD1 oncogene in human neoplasia.","volume":"43","year":"1995","journal-title":"J Investig Med"},{"key":"2020071618434670100_R3","first-page":"1736","article-title":"Cyclin D1\/PRAD1 expression in parathyroid adenomas: an immunohistochemical study.","volume":"81","author":"Hsi","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618434670100_R4","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1126\/science.276.5311.404","article-title":"Positional cloning of the gene for multiple endocrine neoplasia-type 1.","volume":"276","author":"Chandrasekharappa","year":"1997","journal-title":"Science"},{"key":"2020071618434670100_R5","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1038\/ng0897-375","article-title":"Somatic mutation of the MEN1 gene in parathyroid tumours.","volume":"16","author":"Heppner","year":"1997","journal-title":"Nat Genet"},{"key":"2020071618434670100_R6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/gcc.2870130103","article-title":"Frequent loss of chromosome arm 1p DNA in parathyroid adenomas.","volume":"13","author":"Cryns","year":"1995","journal-title":"Genes Chromosom Cancer"},{"key":"2020071618434670100_R7","first-page":"599","article-title":"Genomic localization of novel candidate tumor suppressor gene loci in human parathyroid adenomas.","volume":"56","author":"Tahara","year":"1996","journal-title":"Cancer Res"},{"key":"2020071618434670100_R8","first-page":"3663","article-title":"Loss of chromosome arm 9p DNA and analysis of the p16 and p15 cyclin-dependent kinase inhibitor genes in human parathyroid adenomas.","volume":"81","author":"Tahara","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618434670100_R9","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1056\/NEJM199403173301105","article-title":"Loss of the retinoblastoma tumor-suppressor gene in parathyroid carcinoma.","volume":"330","author":"Cryns","year":"1994","journal-title":"N Engl J Med"},{"key":"2020071618434670100_R10","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1210\/jcem.81.9.8784068","article-title":"Allelic loss of the retinoblastoma tumor suppressor gene: a marker for aggressive parathyroid tumors?","volume":"81","author":"Dotzenrath","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"2020071618434670100_R11","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1365-2265.1996.d01-1561.x","article-title":"Loss of heterozygosity studies at the retinoblastoma and breast cancer susceptibility (BRCA2) loci in pituitary, parathyroid, pancreatic, and carcinoid tumours.","volume":"45","author":"Pearce","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"2020071618434670100_R12","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1126\/science.1359641","article-title":"Comparative genomic hybridization for molecular cytogenetic analysis of solid tumors.","volume":"258","author":"Kallioniemi","year":"1992","journal-title":"Science"},{"key":"2020071618434670100_R13","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/(SICI)1098-2264(199604)15:4<234::AID-GCC5>3.0.CO;2-2","article-title":"Comparative genomic hybridization reveals a specific pattern of chromosomal gains and losses during the genesis of colorectal tumors.","volume":"15","author":"Ried","year":"1996","journal-title":"Genes Chromosom Cancer"},{"key":"2020071618434670100_R14","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1002\/gcc.2870120309","article-title":"Identification of gains and losses of DNA sequences in primary bladder cancer by comparative genomic hybridization.","volume":"12","author":"Kallioniemi","year":"1995","journal-title":"Genes Chromosom Cancer"},{"key":"2020071618434670100_R15","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/(SICI)1098-2264(199610)17:2<78::AID-GCC2>3.0.CO;2-Y","article-title":"Detection of chromosomal DNA gains and losses in testicular germ cell tumors by comparative genomic hybridization.","volume":"17","author":"Korn","year":"1996","journal-title":"Genes Chromosom Cancer"},{"key":"2020071618434670100_R16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/gcc.2870130307","article-title":"Identification of novel regions of altered DNA copy number in small cell lung tumors.","volume":"13","author":"Levin","year":"1995","journal-title":"Genes Chromosom Cancer"},{"key":"2020071618434670100_R17","author":"Sambrook","year":"1989"},{"key":"2020071618434670100_R18","first-page":"1253","article-title":"Comparative genomic hybridization: an overview.","volume":"145","author":"Houldsworth","year":"1994","journal-title":"Am J Pathol"},{"key":"2020071618434670100_R19","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/gcc.2870110304","article-title":"Comparative genomic hybridization, allelic imbalance, and fluorescence in situ hybridization on chromosome 8 in prostate cancer.","volume":"11","author":"Cher","year":"1994","journal-title":"Genes Chromosom Cancer"}],"container-title":["The Journal of Clinical Endocrinology &amp; Metabolism"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/83\/5\/1766\/9231835\/jcem1766.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/jcem\/article-pdf\/83\/5\/1766\/9231835\/jcem1766.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T04:02:00Z","timestamp":1594958520000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jcem\/article\/83\/5\/1766\/2865724"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,5,1]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[1998,5,1]]}},"URL":"https:\/\/doi.org\/10.1210\/jcem.83.5.4806","relation":{},"ISSN":["0021-972X","1945-7197"],"issn-type":[{"value":"0021-972X","type":"print"},{"value":"1945-7197","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,5,1]]}}}